Upon stratification of METABRIC breast cancers into those with “high” and “low” PI3K signaling scores, we found that around 45% of tumors with a high PI3K signaling score were ER-negative, in contrast to 4% of tumors with low PI3K signaling scores (Fig 3A). This evidence concerns the gene ESR1 and breast carcinoma.